BAX · Baxter International Inc
Price
Snapshot
50 fields · last close| Market Cap | $11.79B |
| P/E | — |
| Float | 513.5M |
| Beta | 0.68 |
| Volatility | 17.0% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 74 |
| Price | 22.92 |
| Change | +0.53% |
| Prev Close | 22.80 |
| Open | 23.05 |
| Day Low | 22.71 |
| Day High | 23.16 |
| Avg Vol | 6 |
| Avg $ Vol | $145.3M |
| 52W High | 30.00 |
| 52W Low | 15.73 |
| 52W Pos | 50.4% |
| From High | −23.60% |
| From Low | +45.71% |
| Max DD 1Y | −33.78% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −8.40% |
| SMA 50 | −8.35% |
| SMA 200 | +11.33% |
| RSI (14) | 28.7 |
| Vol 30D | 23.2% |
| Vol 90D | 39.4% |
| 1Y Range | 16–30 |
| Daily bars | 863 |
| Perf Week | −4.20% |
| Perf Month | −14.41% |
| Perf Quarter | +14.63% |
| Perf Half Y | +41.18% |
| Perf Year | −3.76% |
| Perf YTD | +17.54% |
| Prev Day | +0.53% |
| Clavix | B |
| Debt / Eq | 1.54 |
| Curr Ratio | 2.31 |
| Int Cover | -0.9× |
| FCF Margin | 7.5% |
| Rev Growth | +0.1% |
| Profit | Unprofitable |
| Leverage | High |
| Sector rank | 29 / 47 |
What BAX does
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories.
The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services.
Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision.
The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers.
It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand.
Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Clavix risk grade
regraded every trading dayBAX grades B, 74 of 100. Steadiest on News Sentiment (69), most exposed on Sector Resilience (53, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 29 of 47 in Health Care by Clavix score.
How rough the ride is
| BAX | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.68 | 0.85 |
| Volatilityannualized | 17.0% | 21.2% |
| Max drawdown, past yearworst peak-to-trough fall | −33.8% | — |
| Typical daily movemedian absolute daily change | 1.52% | — |
| Days beyond ±3%of the last 252 sessions | 5321% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| BAX | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.68 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| BAX | |
|---|---|
| 1 week | −4.2% |
| 1 month | −14.4% |
| Year to date | +17.5% |
| 1 year | −3.8% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| BAX | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 2 Aug |
| Average score0 most bearish, 100 most bullish | 47 |
| Bullish · bearisharticles above 60 · below 40 | 11 · 13 |
| Directionarticles whose tone is improving vs worsening | 11 ↑ 13 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| BAX | |
|---|---|
| Revenue growthyear over year | +0.1% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openBaxter raised its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs, and pricing pressure continue to weigh on margins.
Baxter raised its 2026 sales and earnings outlook after reporting strong Q2 growth, though profit margins remain under pressure from higher manufacturing costs, tariffs, and pricing headwinds.
Baxter International is recalling IV (intravenous) solutions made at its WNC manufacturing plant. As of Friday, no adverse events had been reported in connection with the recalled product.
Traders bought 6,446 put options on Baxter International on Monday, about 73% more than the usual daily volume of around 3,734.
Baxter International voluntarily recalled certain IV solution bags distributed to 14 states, including Louisiana, between July 31 and Aug. 3 due to potential contamination with fiberglass and stainless steel particles. Affected products include single lots of saline, anticoagulant sodium citrate, and 70% dextrose injection. No patient injuries had been reported to Baxter as of Aug. 25.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| DVA | DaVita Inc | B | $11.73B | 13.84 | 0.88 | Compare |
| BTSG | Brightspring Health Services Inc | B- | $11.23B | 30.70 | 1.89 | Compare |
| PEN | Penumbra Inc | A+ | $12.51B | 77.90 | 0.71 | Compare |
| COO | Cooper Companies Inc | B- | $10.51B | 18.44 | 0.84 | Compare |
| ALGN | Align Technology Inc | B- | $10.49B | 25.35 | 1.74 | Compare |
| MOH | Molina Healthcare Inc | B | $10.48B | 22.21 | 0.73 | Compare |
| UHS | Universal Health Services Inc | A- | $10.41B | 6.82 | 1.12 | Compare |
| GMED | Globus Medical Inc | B | $9.95B | 18.58 | 1.00 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.